Atrial Fibrillation Management During Surgical vs Transcatheter Aortic Valve Replacement.

ABSTRACT:

Background

Societal guidelines support atrial fibrillation (AF) treatment during surgical aortic valve replacement (SAVR). Recently, many patients with AF at low to intermediate risk are managed by transcatheter aortic valve replacement (TAVR). Therefore, we evaluated longitudinal outcomes in these populations.

Methods

The United States Centers for Medicare and Medicaid Services inpatient claims database was evaluated for all beneficiaries with AF undergoing TAVR or SAVR with/without AF treatment (2018-2020). Treatment of AF included concomitant left atrial appendage obliteration, with/without surgical ablation, or endovascular appendage occlusion and/or catheter ablation at any time. Diagnosis-related group and International Classification of Diseases, 10th Revision, codes

SUBMITTER: Mehaffey JH 

PROVIDER: S-EPMC11269036 | biostudies-literature | 2024 Aug

REPOSITORIES: biostudies-literature